Buy or sell InVivo Therapeutics stock pre IPO via an EquityZen fund

EquityZen is a marketplace for shares of proven pre IPO tech companies

InVivo Therapeutics Stock

InVivo Therapeutics is a medical device company focused on developing restoration treatments for patients with spinal cord-injuries.

About InVivo Therapeutics Stock

InVivo Therapeutics Corporation is a Cambridge, MA medical device company focused on utilizing polymers as a platform technology to develop treatments to restore function in individuals paralyzed as a result of traumatic spinal cord injury. The company was founded in 2005 on the basis of research initiated in the laboratories of Robert Langer, PhD, of the Massachusetts Institute of Technology, Jay Vacanti, MD, of the Massachusetts General and Children’s Hospitals in Boston, and Yang Teng, PhD, MD, of Harvard's Brigham and Women's Hospital.

Funding History

December 2010$13.0M
October 2011$30.0M
March 2016$32.2M
January 2018$15.2M



Sean Moran


Kenneth DiPietro

Chief Scientific Officer

Thomas R. Ulich

Director/Non-Executive Chairman of the Board

John A. McCarthy, Jr.

President,CEO & CMO

Richard Toselli

Chief Medical Officer

Lou Vaickus

Interim CFO

Steven F. McAllister

Chief Technology Officer

Brian Hess

Vice President, Business Development

Christopher McNulty

Chief Science Officer

Christopher Pritchard

Other Companies

EquityZen does not have an affiliation with, formal relationship with, or endorsement from InVivo Therapeutics or any companies feature above. This profile is based on publicly available information and is intended to be informative in nature.

Some data provided by Crunchbase

Join 250K+ Investors and Shareholders

On our trusted digital marketplace for private companies

EquityZen Recognized As: